- Original Article
- Published:
Serum thiocyanate concentration as an indicator of smoking in relation to deaths from cancer
Environmental Health and Preventive Medicine volume 6, pages 88–91 (2001)
Abstract
All residents aged 40 years or more in Oyabe City, Toyama Prefecture, Japan were involved in an annual medical check-up between 1987 and 1988. The cohort was followed and death certificates from cancers were confirmed prospectively. During follow-up to December 31 st, 1994, 100 deaths (28 gastric, 17 lung and 55 other cancers) from cancers occurred, and these subjects were included in this study as the case group. Subjects in the control group, matched for gender and age with the cases, were selected randomly from participants whose serum samples had been stocked during annual medical check-up. The concentration of serum thiocyanate in all (79.8 μmol/l), gastric (86.7 μmol/l) and lung (90.0 μmol/l) cancer patients were significantly higher than that of relevant controls (64.3 μmol/l, 59.0 μmol/l and 61.0 μmol/l, respectively; and p<0.001, p<0.001 and p<0.05, respectively). After adjusting for BMI, blood pressure and total serum cholesterol, the results of multiple logistic regression analysis showed that the risk of all cancers (OR=3.40, 95% confidence interval (95% Cl): 1.67–6.96, p<0.01), gastric cancer (OR=7.98, 95% CI: 1.91–33.34, p<0.05) and lung cancer (OR=8.83, 95% CI: 1.19–65.65, p<0.05) were elevated significantly with logarithm transformed values of serum thiocyanate increased. The present findings suggested that in epidemiological studies confirmation of smoking status with biomarkers such as serum thiocyanate may be important, although considering the small sample size, a relatively weaker risk to interested factors rather than the strong relationship between smoking and cancer was noted.
References
Ruth KJ, Neaton JD. Evaluation of tow biological markers of tobacco exposure. Prev. Med. 1991; 20: 574–589.
Vesey CJ, Saloojee Y, Cole PV, Russell MAH. Blood carboxyhaemoglobin, plasma thiocyanate, and cigarette consumption: implications for epidemiological studies in smokers. BMJ 1982; 284: 1516–1518.
Daly RJ, Blann AD. Self-reported smoking in vascular disease: the need for biochemical confirmation. Br. J. Biomed. Sci. 1996: 53: 204–208.
Blann AD, McCollum CN. Adverse influence of cigarette smoking on the endothelium. Thromb. Haemost. 1993; 70: 707–711.
Stookey GK, Katz BP, Olson BL, Drook CA, Cohen SJ. Evaluation of biochemical validation measures in determination of smoking status. J. Dent. Res. 1987; 66: 1597–1601.
Ebeid NI. Thiocyanates in sputum: relation to welding fumes, to-bacco smoking and carcinogenicity. J. Soc. Occup. Med. 1987; 37: 59–61.
Butts CW, Kueneman M, Widdowson GM. Automated method for determining serum thiocyanate to distinguish smokers from non-smokers. Clin. Chem. 1974; 20: 1344–1348.
Vogt TM, Selvins S, Widdowson G et al. Expired air carbon monoxide and serum thiocyanate as objective measures of cigarette exposure. Am. J. Public. Health 1977; 67: 545–549.
SAS/STAT User's Guider. Release 6.03 Edition. Cary, NC: SAS Institute Inc. 1988.
SAS/STAT. Software: Changes and Enhancements through Release 6.12, Cary, NC: SAS Institute Inc. 12, 1997.
Vital statistics of Japan. 1997. Statistics and information department, Minister's secretariat, Ministry of Health and Welfare. 1997.
Klesges RC, Debon M, Ray JW. Are self-reports of smoking rate biased? Evidence from the Second National Health and Nutrition Examination Survey. J. Clin. Epidemiol. 1995; 48: 1225–1233.
Haug K, Foss OP and Kvamme JM. Do pregnant women who report a reduction in cigarette consumption consume less tobacco? Scand. J. Prim. Health Care 1994; 12: 269–275.
Prignot J. Quantification and chemical markers of tobacco-exposure. Eur. J. Respir. Dis. 1987; 70: 1–7.
Woodward M, Tunstall-Pedoe H, Smith WCS, Tavendale R. Smoking characteristics and inhalation biochemistry in the Scottish population. J. Clin. Epidemiol. 1991; 44: 1405–1410.
Bliss RE, O'Connell KA. Problems with thiocyanate as an index of smoking statues. Health Psychol. 1984; 3: 563–581.
Foss OP, Lund-Larsen PG. Serum thiocyanate and smoking: interpretation of serum thiocyanate levels observed in a large health study. Scand. J. Clin. Lab. Invest. 1986; 46: 245–251.
Galvin KT, Kerin MJ, Williams G, Gorst KL, Morgan RH, Kester RC. Comparison of three methods for measuring cigarette smoking in patients with vascular disease. Cardiovasc. Surg. 1994; 2: 48–51.
Densen PM, Davidow B, Bass HE, et al. A chemical test of smoking exposure. Arch. Environ. Health 1967; 14: 864–874.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wang, H., Sekine, M., Yokokawa, H. et al. Serum thiocyanate concentration as an indicator of smoking in relation to deaths from cancer. Environ Health Prev Med 6, 88–91 (2001). https://doi.org/10.1007/BF02897951
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02897951